|
Dec 6
|
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
|
|
Dec 6
|
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
|
|
Nov 27
|
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
|
|
Nov 14
|
Moleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studies
|
|
Nov 10
|
Immunovant (IMVT) Q2 Earnings Top Estimates, Pipeline in Focus
|
|
Nov 9
|
Catalyst (CPRX) Q3 Earnings Miss, Sales Top, '23 View Up
|
|
Oct 31
|
Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
|
|
Aug 31
|
Anixa Biosciences to Participate in September Investor Conferences
|
|
Aug 28
|
Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial
|
|
Jul 14
|
Halozyme (HALO) Rises 5% as Ocrevus SC Meets Goals in MS Study
|
|
Apr 25
|
Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?
|